COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
FrigginYeah Announces Renewed Partnership With South Shore Furniture, Strengthening E-Commerce MAP Monitoring Success
FrigginYeah LLC renews partnership with South Shore Furniture for 2 more years, enhancing brand integrity and compliance. FrigginYeah's MAP Monitoring Software and services prove effective in protecting brand online -
-
COMMUNIQUÉ DE PRESSE
Grid Dynamics and Yieldmo Implement a Next-Generation ML Platform Accelerating Time to Market for New ML Models and Improving Performance for Advertisers
Grid Dynamics and Yieldmo co-innovate to launch a new ML platform for streamlined ad tech processes and optimized ad campaigns, leveraging high scalability and fast time to market -
COMMUNIQUÉ DE PRESSE
LQR House Announces Marketing Partnership Featuring Smoke Lab Vodka
LQR House Inc. partners with Smoke Lab Vodka on a strategic marketing campaign to boost sales. The collaboration showcases distinctive Aniseed and Saffron flavored vodkas, highlighting unique cocktail crafting possibilities -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Net income of the KION Group and adj. EBIT for the SCS segment in Q4 2023 and in the FY 2023 below market expectations; free cash flow of the KION Group for the FY 2023 exceeds market expectations
KION Group's net income and adjusted EBIT for SCS segment in Q4 2023 and FY 2023 fall below market expectations, while free cash flow exceeds expectations. Preliminary results disappoint shareholders -
COMMUNIQUÉ DE PRESSE
Water Technologies International, Inc. Signs Letter of Intent to Acquire Orchard 79 a Residential Community with 87 Single Family Homes to Bolster its Balance Sheet with its Preferred Shares
Water Technologies to acquire 51% of $40M residential community generating $2M annual rental income. Letter of intent with Orchard 79, LLC. nearing completion. Expansion plans for Water Technologies in real estate sector -
COMMUNIQUÉ DE PRESSE
Jaguar Health Announces FDA Agrees with Clinical Trial Protocol for Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Animal Health announces agreement with FDA on clinical field study design for Canalevia-CA1, a canine-specific treatment for chemotherapy-induced diarrhea in dogs, towards full approval
